What is it about?
We conducted a retrospective cohort study (2014–2021) including all hospitalized adult patients with at least one blood culture positive for Enterococcus faecalis or Enterococcus faecium. We included 584 patients with enterococcal BSI: 93 were attributed to vancomycin-resistant E. faecium.
Featured Image
Photo by CDC on Unsplash
Why is it important?
The overall 30-day mortality was 27.5%; higher in cases of BSI due to vancomycin-resistant E. faecium (36.6%) and vancomycin-sensitive E. faecium (31.8%) compared to E. faecalis BSIs (23.2%) (p = 0.016). Male gender, consultation with infectious disease (ID) specialists, and appropriate treatment were associated with reduced mortality (HR = 0.666, p = 0.014; HR = 0.504, p < 0.001; HR = 0.682, p = 0.026, respectively)
Read the Original
This page is a summary of: Risk Factors for 30-Day Mortality in Nosocomial Enterococcal Bloodstream Infections, Antibiotics, June 2024, MDPI AG,
DOI: 10.3390/antibiotics13070601.
You can read the full text:
Contributors
The following have contributed to this page
